{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:57:46Z","timestamp":1790233066631,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.amjcard.2005.11.039","type":"journal-article","created":{"date-parts":[[2006,3,4]],"date-time":"2006-03-04T12:24:05Z","timestamp":1141475045000},"page":"1198-1205","source":"Crossref","is-referenced-by-count":85,"title":["Effects of Colesevelam Hydrochloride on Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein When Added to Statins in Patients With Hypercholesterolemia"],"prefix":"10.1016","volume":"97","author":[{"given":"Harold E.","family":"Bays","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey L.","family":"Abby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2005.11.039_bib1","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.11.039_bib2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.1984.03340270029025","article-title":"The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease","volume":"251","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2005.11.039_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.1984.03340270043026","article-title":"The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering","volume":"251","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2005.11.039_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.CIR.69.2.313","article-title":"Effects of therapy with cholestyramine on progression of coronary arteriosclerosis","volume":"69","author":"Brensike","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.11.039_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/01.CIR.69.2.325","article-title":"The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease","volume":"69","author":"Levy","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.11.039_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0140-6736(92)90863-X","article-title":"Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas\u2019 Atherosclerosis Regression Study (STARS)","volume":"339","author":"Watts","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2005.11.039_bib7","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1001\/jama.1987.03390230069027","article-title":"Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts","volume":"257","author":"Blankenhorn","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2005.11.039_bib8","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM199011083231901","article-title":"Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B","volume":"323","author":"Brown","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2005.11.039_bib9","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1001\/jama.1990.03450230043027","article-title":"Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens","volume":"264","author":"Kane","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2005.11.039_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.7326\/0003-4819-142-2-200501180-00008","article-title":"A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels","volume":"142","author":"Whitney","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2005.11.039_bib11","first-page":"779","article-title":"Colesevelam HCl","volume":"4","author":"Bays","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.amjcard.2005.11.039_bib12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/clc.4960240610","article-title":"Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia","volume":"24","author":"Davidson","year":"2001","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2005.11.039_bib13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0021-9150(01)00437-3","article-title":"Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively","volume":"158","author":"Hunninghake","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2005.11.039_bib14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0002-9343(01)00638-6","article-title":"Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia","volume":"110","author":"Knapp","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2005.11.039_bib15","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.amjcard.2004.07.122","article-title":"Impact of nonprescriptive factors on low-density lipoprotein cholesterol reduction with statins","volume":"94","author":"Frolkis","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2005.11.039_bib16","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ahj.2004.07.023","article-title":"Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients","volume":"149","author":"Ferramosca","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2005.11.039_bib17","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/archinte.162.14.1568","article-title":"Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes","volume":"162","author":"Grundy","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2005.11.039_bib18","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0002-9149(01)02338-4","article-title":"Long-term safety and efficacy of a once-daily niacin\/lovastatin formulation for patients with dyslipidemia","volume":"89","author":"Kashyap","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2005.11.039_bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.atherosclerosis.2004.10.021","article-title":"Effects of ezetimibe coadministered with simvastatin on C-reactive protein in a large cohort of hypercholesterolemic patients","volume":"179","author":"Sager","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2005.11.039_bib20","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.clinthera.2004.11.016","volume":"26","author":"Bays","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjcard.2005.11.039_bib21","doi-asserted-by":"crossref","first-page":"III39","DOI":"10.1002\/clc.4960261508","article-title":"Connecting the role of C-reactive protein and statins in cardiovascular disease","volume":"26","author":"Ridker","year":"2003","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2005.11.039_bib22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0115426503018003227","article-title":"C-reactive proteins and chronic disease","volume":"18","author":"Liepa","year":"2003","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.amjcard.2005.11.039_bib23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0021-9150(01)00633-5","article-title":"C-reactive protein and other markers of inflammation among patients undergoing HELP LDL apheresis","volume":"158","author":"Moriarity","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2005.11.039_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/000331970205300304","article-title":"Effect of ciprofibrate on C-reactive protein and fibrinogen levels","volume":"53","author":"Rizos","year":"2002","journal-title":"Angiology"},{"key":"10.1016\/j.amjcard.2005.11.039_bib25","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1160\/TH03-04-0250","article-title":"Statin and fibrate treatment of combined hyperlipidemia","volume":"92","author":"Sebestjen","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2005.11.039_bib26","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/31701","article-title":"Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators","volume":"393","author":"Staels","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.amjcard.2005.11.039_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0021-9150(03)00296-X","article-title":"Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia","volume":"170","author":"Wang","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2005.11.039_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-0038-1655910","article-title":"Modulation of plasma fibrinogen levels by ciprofibrate and gemfibrozil in primary hyperlipidemia","volume":"77","author":"De-Maat","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2005.11.039_bib29","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.CIR.100.8.793","article-title":"Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin","volume":"100","author":"Ikonomidis","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2005.11.039_bib30","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1538-7836.2004.01017.x","article-title":"A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C-reactive protein following myocardial infarction","volume":"2","author":"Woodward","year":"2004","journal-title":"J Thromb Haemost"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914906000439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914906000439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T05:18:32Z","timestamp":1555478312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914906000439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0002914906000439"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2005.11.039","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}